CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages

被引:153
|
作者
Katakura, T
Miyazaki, M
Kobayashi, M
Herndon, DN
Suzuki, F
机构
[1] Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77555 USA
[2] Chiba Univ, Grad Sch Med, Dept Gen Surg, Chiba, Japan
[3] Shriners Hosp Children, Galveston, TX 77555 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 172卷 / 03期
关键词
D O I
10.4049/jimmunol.172.3.1407
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Classically activated macrophages (CAMO) have been described as a major effector cell on the host's innate immunities. However, CAMphi are not generated in immunocompromised hosts whose alternatively activated macrophages (AAMphi) predominate. In this study, the mechanism by which AAMphi suppress the ability of resident macrophages (RMphi) to generate CAMphi was investigated. AAMphi were isolated from peritoneal exudates of mice 2 days after third-degree thermal injuries affecting 15% total body surface area. CAMphi were generated from RMphi (peritoneal Mphi from normal mice) through stimulation with CpG DNA, a typical CAMphi inducer. RMphi did not polarize to CAMphi when they were cultured with AAMphi in a dual-chamber Transwell even when supplemented with CpG DNA. In addition, RMphi stimulated with CpG DNA did not convert to CAMphi when they were cultured with the culture fluids of AAMphi (AAMphi Culture-Sup). AAMphi Culture-Sup contained IL-6, IL-10, CCL17, PGE(2), and TGF-beta. Among these, CCL17 and IL-10 inhibited CAMO generation. The ability of AAMphi Culture-Sup to inhibit CAMphi generation was eliminated when the Culture-Sup was treated with a mixture of mAbs directed against CCL17 and IL-10. These results indicate that CCL17 and IL-10 released from AAMphi inhibit CAMphi generation from RMphi stimulated with CpG DNA.
引用
收藏
页码:1407 / 1413
页数:7
相关论文
共 50 条
  • [31] IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients
    Prasse, Antje
    Germann, Martin
    Pechkovsky, Dmitri V.
    Markert, Anna
    Verres, Tibor
    Stahl, Mirjam
    Melchers, Inga
    Luttmann, Werner
    Mueller-Quernheim, Joachim
    Zissel, Gernot
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) : 464 - 471
  • [32] Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages
    Yoshida, Tsuyoshi
    Tsuda, Yasuhiro
    Takeuchi, Dan
    Kobayashi, Makiko
    Pollard, Richard B.
    Suzuki, Fujio
    CYTOKINE, 2006, 33 (06) : 317 - 322
  • [33] Inhibitory effect of glycyrrhizin-derivatives on the generation of alternatively activated macrophages
    Kobayashi, M
    Yoshida, T
    Matsumoto, H
    Tsukahara, M
    Pollard, RB
    Suzuki, F
    FASEB JOURNAL, 2005, 19 (05): : A1446 - A1446
  • [34] Alternatively Activated Macrophages Elicited by Helminth Infection Can Be Reprogrammed to Enable Microbial Killing
    Mylonas, Katie J.
    Nair, Meera G.
    Prieto-Lafuente, Lidia
    Paape, Daniel
    Allen, Judith E.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 3084 - 3094
  • [35] Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages
    Rizzo, Angelamaria
    Monteleone, Ivan
    Fina, Daniele
    Stolfi, Carmine
    Caruso, Roberta
    Fantini, Massimo Claudio
    Franze', Eleonora
    Schwendener, Reto
    Pallone, Francesco
    Monteleone, Giovanni
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (03) : 449 - 459
  • [36] INHIBITION OF COLITIS BY IL-25 ASSOCIATES WITH INDUCTION OF ALTERNATIVELY ACTIVATED MACROPHAGES
    Rizzo, A.
    Monteleone, I.
    Fina, D.
    Stolfi, C.
    Caruso, R.
    Fantini, M. C.
    Schwendener, R.
    De Nitto, D.
    Franze, E.
    Pallone, F.
    Monteleone, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S130 - S130
  • [37] Augmentation of alternatively activated macrophages by IL-4 for the treatment of myocardial infarction
    Shintani, Y.
    Ito, T.
    Laura, F.
    Ichihara, Y.
    Tanaka, H.
    Suzuki, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 904 - 904
  • [38] Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis
    Zsófia Varga
    Tamás Molnár
    Anett Mázló
    Ramóna Kovács
    Viktória Jenei
    Krisztina Kerekes
    Attila Bácsi
    Gábor Koncz
    Cancer Immunology, Immunotherapy, 2020, 69 : 2193 - 2207
  • [39] Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis
    Varga, Zsofia
    Molnar, Tamas
    Mazlo, Anett
    Kovacs, Ramona
    Jenei, Viktoria
    Kerekes, Krisztina
    Bacsi, Attila
    Koncz, Gabor
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (11) : 2193 - 2207
  • [40] Morphologic, phenotypic, and transcriptomic characterization of classically and alternatively activated canine blood-derived macrophages in vitro
    Heinrich, Franziska
    Lehmbecker, Annika
    Raddatz, Barbara B.
    Kegler, Kristel
    Tipold, Andrea
    Stein, Veronika M.
    Kalkuhl, Arno
    Deschl, Ulrich
    Baumgaertner, Wolfgang
    Ulrich, Reiner
    Spitzbarth, Ingo
    PLOS ONE, 2017, 12 (08):